Showing results (51-60 of 171) with videos related to

Sort By:
Pageof 18
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 19, 2015
Pre-treatment blood inflammatory markers as predictors of systemic infection during induction chemotherapy: results of an exploratory study in patients with acute myeloid leukemiaJunshik Hong, Hyun Seon Woo, Hee Kyung Ahn, et al.
British Journal of Cancer|March 24, 2020
Decreased vitamin C uptake mediated by SLC2A3 promotes leukaemia progression and impedes TET2 restorationJun Liu, Junshik Hong, Heejoo Han, et al.
Blood Transfusion = Trasfusione Del Sangue|May 26, 2023
A pilot randomized study for optimal red cell transfusion in acute myeloid leukemia patients with intensive chemotherapyJa Min Byun, Woochan Park, Dong-Yeop Shin, et al.
Cancer Research and Treatment|April 7, 2010
Oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) combination chemotherapy as a salvage treatment in advanced gastric cancerYoung Saing Kim, Junshik Hong, Sun Jin Sym, et al.
Annals of Hematology|April 5, 2018
Temporal trajectory of quality of life and its predictors in recipients of hematopoietic stem cell transplantationRyul Kim, Kyung-Lak Son, Kwang-Min Lee, et al.
Scientific Reports|September 9, 2021
Incidence, characteristics and risk factors of thromboembolic events in East Asian patients with BCR-ABL1 negative myeloproliferative neoplasmsJinyong Kim, Ja Min Byun, Junshik Hong, et al.
Medicine|February 16, 2024
Treatment outcomes and prognostic factors of patients with lymphoblastic lymphoma in East AsiaJinyong Kim, Ja Min Byun, Junshik Hong, et al.
Stem Cell Reviews and Reports|June 10, 2022
Expansion of Human Megakaryocyte-Lineage Progeny via Aryl Hydrocarbon Receptor Antagonism with CH223191Dongchan Kim, Dong-Yeop Shin, Jun Liu, et al.
Blood Research|July 7, 2016
Baseline renal function as a prognostic indicator in patients with newly diagnosed diffuse large B-cell lymphomaJunshik Hong, Sojung Lee, Gayoung Chun, et al.
Therapeutic Advances in Hematology|December 25, 2025
Real-world experience with tisagenlecleucel for the treatment of relapsed or refractory diffuse large B-cell lymphoma in KoreaDong Hyun Kim, Soyean Kwon, Seungah Cha, et al.
Pageof 18